0001415889-24-002121.txt : 20240131 0001415889-24-002121.hdr.sgml : 20240131 20240131205357 ACCESSION NUMBER: 0001415889-24-002121 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240131 FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rosett Max CENTRAL INDEX KEY: 0001994071 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39580 FILM NUMBER: 24584702 MAIL ADDRESS: STREET 1: C/O MORPHIMMUNE INC. STREET 2: 101 FOUNDRY DRIVE, SUITE 1200 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immunome Inc. CENTRAL INDEX KEY: 0001472012 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770694340 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 610-321-3700 MAIL ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 4 1 form4-02012024_010250.xml X0508 4 2024-01-31 0001472012 Immunome Inc. IMNM 0001994071 Rosett Max C/O IMMUNOME, INC. 665 STOCKTON DRIVE, SUITE 300 EXTON PA 19341 false true false false EVP, OPERATIONS & INTERIM CFO 0 Stock option (right to buy) 16.57 2024-01-31 4 A 0 175000 0 A 2034-01-30 Common Stock 175000 175000 D 25% of the shares subject to the options vest on January 31, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter. /s/ Sandra Stoneman, Attorney-in-Fact 2024-01-31